nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—RBP4—metabolic syndrome X	0.00708	0.00708	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00689	0.00689	CbGpPWpGaD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—SCARB1—metabolic syndrome X	0.00678	0.00678	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00618	0.00618	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—SCARB1—metabolic syndrome X	0.00609	0.00609	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00593	0.00593	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—metabolic syndrome X	0.00592	0.00592	CbGpPWpGaD
Tazarotene—CYP2C8—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.00587	0.00587	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—SCARB1—metabolic syndrome X	0.00583	0.00583	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—SCARB1—metabolic syndrome X	0.00583	0.00583	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—RETN—metabolic syndrome X	0.00548	0.00548	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—metabolic syndrome X	0.00531	0.00531	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NR1H3—metabolic syndrome X	0.00527	0.00527	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARA—metabolic syndrome X	0.00509	0.00509	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARA—metabolic syndrome X	0.00509	0.00509	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—metabolic syndrome X	0.00489	0.00489	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00478	0.00478	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—NR3C1—metabolic syndrome X	0.00466	0.00466	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—SCD—metabolic syndrome X	0.00466	0.00466	CbGpPWpGaD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—LPL—metabolic syndrome X	0.00448	0.00448	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—metabolic syndrome X	0.00439	0.00439	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—PPARA—metabolic syndrome X	0.00437	0.00437	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00428	0.00428	CbGpPWpGaD
Tazarotene—RARG—Vitamin A and Carotenoid Metabolism—CD36—metabolic syndrome X	0.00426	0.00426	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—metabolic syndrome X	0.00421	0.00421	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—metabolic syndrome X	0.00421	0.00421	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—NR3C1—metabolic syndrome X	0.00418	0.00418	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00411	0.00411	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—LPL—metabolic syndrome X	0.00402	0.00402	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—NR3C1—metabolic syndrome X	0.00401	0.00401	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—NR3C1—metabolic syndrome X	0.00401	0.00401	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00395	0.00395	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—PPARA—metabolic syndrome X	0.00392	0.00392	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—LPL—metabolic syndrome X	0.00385	0.00385	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—LPL—metabolic syndrome X	0.00385	0.00385	CbGpPWpGaD
Tazarotene—RARB—Vitamin A and Carotenoid Metabolism—CD36—metabolic syndrome X	0.00382	0.00382	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—PPARA—metabolic syndrome X	0.00376	0.00376	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—PPARA—metabolic syndrome X	0.00376	0.00376	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.00369	0.00369	CbGpPWpGaD
Tazarotene—RXRB—Vitamin A and Carotenoid Metabolism—CD36—metabolic syndrome X	0.00366	0.00366	CbGpPWpGaD
Tazarotene—RARA—Vitamin A and Carotenoid Metabolism—CD36—metabolic syndrome X	0.00366	0.00366	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptors—PPARG—metabolic syndrome X	0.00361	0.00361	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00354	0.00354	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—SIRT1—metabolic syndrome X	0.00346	0.00346	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.00345	0.00345	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.0034	0.0034	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.00331	0.00331	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptors—PPARG—metabolic syndrome X	0.00324	0.00324	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.00317	0.00317	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.00317	0.00317	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptors—PPARG—metabolic syndrome X	0.00311	0.00311	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptors—PPARG—metabolic syndrome X	0.00311	0.00311	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.0031	0.0031	CbGpPWpGaD
Tazarotene—RXRB—Regulation of Androgen receptor activity—NR3C1—metabolic syndrome X	0.00307	0.00307	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.00297	0.00297	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.00297	0.00297	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TRIB3—metabolic syndrome X	0.00292	0.00292	CbGpPWpGaD
Tazarotene—RARG—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.00285	0.00285	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—metabolic syndrome X	0.00278	0.00278	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NAMPT—metabolic syndrome X	0.00262	0.00262	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.00261	0.00261	CbGpPWpGaD
Tazarotene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—metabolic syndrome X	0.0026	0.0026	CbGpPWpGaD
Tazarotene—RARB—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.00256	0.00256	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—metabolic syndrome X	0.0025	0.0025	CbGpPWpGaD
Tazarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.00245	0.00245	CbGpPWpGaD
Tazarotene—RARA—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.00245	0.00245	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—metabolic syndrome X	0.00239	0.00239	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—metabolic syndrome X	0.00239	0.00239	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—HMGA1—metabolic syndrome X	0.00238	0.00238	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—SREBF1—metabolic syndrome X	0.00234	0.00234	CbGpPWpGaD
Tazarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—metabolic syndrome X	0.00233	0.00233	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.00224	0.00224	CbGpPWpGaD
Tazarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—metabolic syndrome X	0.00223	0.00223	CbGpPWpGaD
Tazarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—metabolic syndrome X	0.00223	0.00223	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—ADIPOQ—metabolic syndrome X	0.00215	0.00215	CbGpPWpGaD
Tazarotene—CYP2C8—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00205	0.00205	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—SLC2A4—metabolic syndrome X	0.00203	0.00203	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.00201	0.00201	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.00192	0.00192	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.00192	0.00192	CbGpPWpGaD
Tazarotene—RARG—Retinoic acid receptors-mediated signaling—AKT1—metabolic syndrome X	0.00173	0.00173	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.00164	0.00164	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—LPL—metabolic syndrome X	0.00159	0.00159	CbGpPWpGaD
Tazarotene—RARB—Retinoic acid receptors-mediated signaling—AKT1—metabolic syndrome X	0.00155	0.00155	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—NR3C1—metabolic syndrome X	0.0015	0.0015	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.0015	0.0015	CbGpPWpGaD
Tazarotene—RARA—Retinoic acid receptors-mediated signaling—AKT1—metabolic syndrome X	0.00148	0.00148	CbGpPWpGaD
Tazarotene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—metabolic syndrome X	0.00148	0.00148	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—EDC4—metabolic syndrome X	0.00148	0.00148	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.00147	0.00147	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.00141	0.00141	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.00141	0.00141	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARA—metabolic syndrome X	0.0014	0.0014	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—AGT—metabolic syndrome X	0.00136	0.00136	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.00134	0.00134	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—LEP—metabolic syndrome X	0.00133	0.00133	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—EDC4—metabolic syndrome X	0.00132	0.00132	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.0013	0.0013	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.00129	0.00129	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.00129	0.00129	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—EDC4—metabolic syndrome X	0.00127	0.00127	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—EDC4—metabolic syndrome X	0.00127	0.00127	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.00124	0.00124	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.00124	0.00124	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	0.00119	0.00119	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IRS1—metabolic syndrome X	0.00119	0.00119	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—PPARG—metabolic syndrome X	0.00116	0.00116	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—INS—metabolic syndrome X	0.00114	0.00114	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IGF1—metabolic syndrome X	0.0011	0.0011	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—FMO3—metabolic syndrome X	0.00109	0.00109	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR1H3—metabolic syndrome X	0.00108	0.00108	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00108	0.00108	CbGpPWpGaD
Tazarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—metabolic syndrome X	0.00107	0.00107	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—SERPINE1—metabolic syndrome X	0.00105	0.00105	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.00101	0.00101	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR1H3—metabolic syndrome X	0.000967	0.000967	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000959	0.000959	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR1H3—metabolic syndrome X	0.000927	0.000927	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR1H3—metabolic syndrome X	0.000927	0.000927	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.000845	0.000845	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.000832	0.000832	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	0.00081	0.00081	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR1I3—metabolic syndrome X	0.000789	0.000789	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR1I2—metabolic syndrome X	0.000721	0.000721	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR1I3—metabolic syndrome X	0.000707	0.000707	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.0007	0.0007	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR1I3—metabolic syndrome X	0.000678	0.000678	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR1I3—metabolic syndrome X	0.000678	0.000678	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	0.000671	0.000671	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TGFB1—metabolic syndrome X	0.00066	0.00066	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR1I2—metabolic syndrome X	0.000647	0.000647	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.000637	0.000637	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR1I2—metabolic syndrome X	0.00062	0.00062	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR1I2—metabolic syndrome X	0.00062	0.00062	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—metabolic syndrome X	0.000617	0.000617	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.000596	0.000596	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.000571	0.000571	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.000547	0.000547	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.000547	0.000547	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.000535	0.000535	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.000513	0.000513	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.000513	0.000513	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000506	0.000506	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—metabolic syndrome X	0.000498	0.000498	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—PPARG—metabolic syndrome X	0.000493	0.000493	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.000485	0.000485	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000473	0.000473	CbGpPWpGaD
Tazarotene—CYP2C8—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.000469	0.000469	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	0.000453	0.000453	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	0.000444	0.000444	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—PPARG—metabolic syndrome X	0.000442	0.000442	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—PPARG—metabolic syndrome X	0.000424	0.000424	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—PPARG—metabolic syndrome X	0.000424	0.000424	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	0.000398	0.000398	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	0.000382	0.000382	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	0.000382	0.000382	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GGT1—metabolic syndrome X	0.000375	0.000375	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000374	0.000374	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000352	0.000352	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SIRT1—metabolic syndrome X	0.000345	0.000345	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000337	0.000337	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SIRT1—metabolic syndrome X	0.00031	0.00031	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR3C1—metabolic syndrome X	0.000306	0.000306	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.000299	0.000299	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SIRT1—metabolic syndrome X	0.000297	0.000297	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SIRT1—metabolic syndrome X	0.000297	0.000297	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARA—metabolic syndrome X	0.000287	0.000287	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.000283	0.000283	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR3C1—metabolic syndrome X	0.000275	0.000275	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR3C1—metabolic syndrome X	0.000264	0.000264	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR3C1—metabolic syndrome X	0.000264	0.000264	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARA—metabolic syndrome X	0.000258	0.000258	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARA—metabolic syndrome X	0.000247	0.000247	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARA—metabolic syndrome X	0.000247	0.000247	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.000246	0.000246	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.000241	0.000241	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PPARG—metabolic syndrome X	0.000237	0.000237	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.000233	0.000233	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.000231	0.000231	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.000215	0.000215	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—SERPINE1—metabolic syndrome X	0.000214	0.000214	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PPARG—metabolic syndrome X	0.000213	0.000213	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PPARG—metabolic syndrome X	0.000204	0.000204	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PPARG—metabolic syndrome X	0.000204	0.000204	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SERPINE1—metabolic syndrome X	0.000192	0.000192	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.000191	0.000191	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.00019	0.00019	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FMO3—metabolic syndrome X	0.000187	0.000187	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.000184	0.000184	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SERPINE1—metabolic syndrome X	0.000184	0.000184	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SERPINE1—metabolic syndrome X	0.000184	0.000184	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.000177	0.000177	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.000172	0.000172	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.000167	0.000167	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MLXIPL—metabolic syndrome X	0.000166	0.000166	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—EPHX2—metabolic syndrome X	0.000166	0.000166	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—G6PC2—metabolic syndrome X	0.000156	0.000156	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000149	0.000149	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.000144	0.000144	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FABP4—metabolic syndrome X	0.000133	0.000133	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HSD11B1—metabolic syndrome X	0.000126	0.000126	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000122	0.000122	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000119	0.000119	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000117	0.000117	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—G6PD—metabolic syndrome X	0.000112	0.000112	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000111	0.000111	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HDAC3—metabolic syndrome X	0.00011	0.00011	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCKR—metabolic syndrome X	0.000107	0.000107	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPA—metabolic syndrome X	0.000107	0.000107	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G6—metabolic syndrome X	0.000104	0.000104	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000103	0.000103	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA5—metabolic syndrome X	0.000103	0.000103	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	9.98e-05	9.98e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	9.78e-05	9.78e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	9.67e-05	9.67e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TRIB3—metabolic syndrome X	9.56e-05	9.56e-05	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—metabolic syndrome X	9.39e-05	9.39e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NAMPT—metabolic syndrome X	8.57e-05	8.57e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	8.52e-05	8.52e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LIPC—metabolic syndrome X	8.52e-05	8.52e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GCK—metabolic syndrome X	8.52e-05	8.52e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOC3—metabolic syndrome X	8.46e-05	8.46e-05	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—metabolic syndrome X	8.42e-05	8.42e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CETP—metabolic syndrome X	8.22e-05	8.22e-05	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—metabolic syndrome X	8.07e-05	8.07e-05	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—metabolic syndrome X	8.07e-05	8.07e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	7.87e-05	7.87e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	7.66e-05	7.66e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	7.64e-05	7.64e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GOT2—metabolic syndrome X	7.43e-05	7.43e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	7.43e-05	7.43e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	6.7e-05	6.7e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	6.62e-05	6.62e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	6.62e-05	6.62e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GGT1—metabolic syndrome X	6.41e-05	6.41e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GOT1—metabolic syndrome X	6.41e-05	6.41e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOB—metabolic syndrome X	5.44e-05	5.44e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	5.29e-05	5.29e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—LPL—metabolic syndrome X	5.2e-05	5.2e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CD36—metabolic syndrome X	4.94e-05	4.94e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARA—metabolic syndrome X	4.59e-05	4.59e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AGT—metabolic syndrome X	4.45e-05	4.45e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOE—metabolic syndrome X	4.36e-05	4.36e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—APOA1—metabolic syndrome X	4.31e-05	4.31e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PPARG—metabolic syndrome X	3.79e-05	3.79e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—INS—metabolic syndrome X	3.72e-05	3.72e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—metabolic syndrome X	3.41e-05	3.41e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NOS3—metabolic syndrome X	3.26e-05	3.26e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	2.98e-05	2.98e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—metabolic syndrome X	1.5e-05	1.5e-05	CbGpPWpGaD
